Correlation Between Equillium and Rani Therapeutics
Can any of the company-specific risk be diversified away by investing in both Equillium and Rani Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Rani Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and Rani Therapeutics Holdings, you can compare the effects of market volatilities on Equillium and Rani Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Rani Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Rani Therapeutics.
Diversification Opportunities for Equillium and Rani Therapeutics
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Equillium and Rani is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Rani Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rani Therapeutics and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Rani Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rani Therapeutics has no effect on the direction of Equillium i.e., Equillium and Rani Therapeutics go up and down completely randomly.
Pair Corralation between Equillium and Rani Therapeutics
Allowing for the 90-day total investment horizon Equillium is expected to under-perform the Rani Therapeutics. In addition to that, Equillium is 1.46 times more volatile than Rani Therapeutics Holdings. It trades about -0.03 of its total potential returns per unit of risk. Rani Therapeutics Holdings is currently generating about 0.01 per unit of volatility. If you would invest 142.00 in Rani Therapeutics Holdings on December 27, 2024 and sell it today you would lose (8.00) from holding Rani Therapeutics Holdings or give up 5.63% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Equillium vs. Rani Therapeutics Holdings
Performance |
Timeline |
Equillium |
Rani Therapeutics |
Equillium and Rani Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Equillium and Rani Therapeutics
The main advantage of trading using opposite Equillium and Rani Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Rani Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rani Therapeutics will offset losses from the drop in Rani Therapeutics' long position.Equillium vs. Lyra Therapeutics | Equillium vs. Hookipa Pharma | Equillium vs. Jasper Therapeutics | Equillium vs. Cingulate Warrants |
Rani Therapeutics vs. Vincerx Pharma | Rani Therapeutics vs. Tenaya Therapeutics | Rani Therapeutics vs. Corvus Pharmaceuticals | Rani Therapeutics vs. Alx Oncology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |